Diversify Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Diversify Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$428K	Sell	10,025 -975	-9%	-$24.1K	0.01%	917
2026 Q1	$225K	Buy	11,000 +1,000	+10%	+$17K	﹤0.01%	1055
2025 Q4	$149K	Hold	10,000	–	–	0.01%	605
2025 Q3	$123K	Hold	10,000	–	–	0.01%	526
2025 Q2	$102K	Hold	10,000	–	–	0.01%	527
2025 Q1	$63K	Hold	10,000	–	–	﹤0.01%	506
2024 Q4	$69.3K	Hold	10,000	–	–	0.01%	508
2024 Q3	$62.2K	Hold	10,000	–	–	0.01%	463
2024 Q2	$74.7K	Buy	+10,000	New	+$87.5K	0.01%	425

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Diversify Wealth Management's DFTX Position: Q2 2026 in Review

Diversify Wealth Management reduced its Definium Therapeutics (DFTX) stake by 8.9% in Q2 2026, selling an estimated $24.1K and leaving 10,025 shares worth $428K. The position accounts for 0.01% of the portfolio, ranked #917.

Diversify Wealth Management first reported a position in DFTX in Q2 2024 and has held it in 9 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Diversify Wealth Management held 10,025 shares of Definium Therapeutics worth $428K as of Q2 2026.
Diversify Wealth Management sold 975 Definium Therapeutics shares in Q2 2026, an estimated $24.1K.
Definium Therapeutics made up 0.01% of Diversify Wealth Management's portfolio in Q2 2026, its #917 holding.
Diversify Wealth Management first reported a position in Definium Therapeutics in Q2 2024 and has held it in 9 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Diversify Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.